Spelling suggestions: "subject:"kidneys."" "subject:"sidneys.""
51 |
The many facets of the renal proximal tubular epithelial cell in humanTang, Chi-wai, Sydney. January 2005 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2005. / Title proper from title frame. Also available in printed format.
|
52 |
Mesangial cell apoptosis and phagocytosis : the role of glucose and transforming growth factor beta-1Khera, Tarnjit Kaur January 2006 (has links)
No description available.
|
53 |
Knowledge of dialysis patients on kidney transplantation廖華苓, Liu, Wa-ling. January 2005 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
54 |
The investigation of early physiological changes in renal function in childhood diabetesCampbell, Fiona M. January 1998 (has links)
No description available.
|
55 |
The effect of immunosuppressants in a mouse model of glomerulonephritisGill, Diana J. January 1994 (has links)
This study compared the effect of various immunosuppressive therapies on the development of lupus nephritis using a murine model of SLE, the MRL lpr/lpr mouse. The agents investigated were cyclosporin A (CsA), FK506, rapamycin and mycophenolate mofetil (MM). Female MRL lpr/lpr mice at 12 weeks old were treated with CsA (40mg/kg/day p.o.), FK506 (2.5mg/kg/3 times/week or/day s.c.), rapamycin (1.5mg/kg.day s.c.), MM (50mg/kg/2 times daily p.o.) or vehicle controls. These groups were compared with untreated MRL lpr/lpr and also untreated MRL +/+ mice which do not develop this autoimmune disease. Disease progression was assessed using various markers for SLE and glomerular dysfunction. The results obtained showed CsA and rapamycin to both inhibit glomerular proliferation and reduce glomerular macrophage infiltrate. In addition, rapamycin also reduced chronic inflammatory cell infiltrate, lymphadenopathy and splenomegaly. Rapamycin treated animals did not develop skin lesions and alopecia which became apparent on mice from other groups. In contrast neither low or high dose FK506 treatments prevented the development of the autoimmune pathological features, including renal disease. Likewise, mycophenolate mofetil had no beneficial effects in disease prevention. In conclusion, it appears that both rapamycin and CsA but not FK506 or mycophenolate mofetil reduce macrophage infiltration, glomerular proliferation and, in the case of rapamycin chronic inflammatory cell infiltrate and lymphadenopathy, in the MRL lpr/lpr mouse.
|
56 |
Intravascular coagulation in renal diseaseClarkson, Anthony Russell January 1972 (has links)
212 leaves : / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (M.D.)--University of Adelaide, Dept. of Medicine, 1973
|
57 |
Intravascular coagulation in renal diseaseClarkson, Anthony Russell. January 1972 (has links) (PDF)
No description available.
|
58 |
RET receptor tyrosine kinase in developing, adult and polycystic kidneysLee, Chun-wai, Davy. January 2000 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2001. / Includes bibliographical references (leaves 148-170).
|
59 |
Statistical validation of kidney deficiency syndromes (KDS) and the development of a KDS questionnaire in Hong Kong Chinese women aged 40-60 yearsChen, Runqiu. January 2009 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 286-318). Also available in print.
|
60 |
Statistical validation of kidney deficiency syndromes (KDS) and the development of a KDS questionnaire in Hong Kong Chinese women aged 40-60 years /Chen, Runqiu. January 2009 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 286-318). Also available online.
|
Page generated in 0.0315 seconds